Summit Securities Group’s Repligen RGEN Stock Holding History

Summit Securities Group’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-25	Closed	-$486K	–	832
2021 Q1	$486K	Buy	+25	New	+$5.13K	0.05%	326

Other funds holding RGEN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Summit Securities Group's RGEN Position: Q2 2025 in Review

Summit Securities Group sold out of Repligen (RGEN) in Q2 2025, closing a stake of 1,298 shares — an estimated $165K sold.

Summit Securities Group first reported a position in RGEN in Q1 2025 and held it in 1 quarter. The position peaked at $165K in Q1 2025. 443 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.

Summit Securities Group reported no remaining Repligen position as of Q2 2025 after selling out during the quarter.
Summit Securities Group sold 1,298 Repligen shares in Q2 2025, an estimated $165K.
Summit Securities Group first reported a position in Repligen in Q1 2025 and held it in 1 quarter.
Summit Securities Group's Repligen position peaked at $165K in Q1 2025.
443 funds tracked by Wall St. Rank held Repligen as of Q2 2025.

Based on Summit Securities Group's 13F filing for Q2 2025, filed 12 Aug 2025.